Clinical Trials Directory

Trials / Unknown

UnknownNCT05493644

A Study About the Selection of Time for Retreatment of Helicobacter Pylori After Eradication Failure

Status
Unknown
Phase
Study type
Observational
Enrollment
660 (estimated)
Sponsor
Shandong University · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

The patients who accepted the quadruple eradication program of the helicobacter pylori but failed to eradicate helicobacter pylori will be assessed the most suitable re-eradication time of helicobacter pylori.

Detailed description

Helicobacter pylori (HP) infection is a common global infectious disease, which is an important cause of chronic gastritis, peptic ulcer and gastric cancer. At present, due to the non-standard Helicobacter pylori eradication program in clinical work, poor patient compliance and other reasons, the phenomenon of HP eradication treatment failure is more and more common. However, there is still no conclusion on the most appropriate time for remedial treatment inpatients with Hp eradication failure.

Conditions

Interventions

TypeNameDescription
OTHERRemedial treatment within 3 monthsRemedial therapy was performed within 3 months
OTHERRemedial treatment within 3 to 6 monthsRemedial therapy was performed within 3 to 6 months
OTHERRemedial treatment within 6 to 12 monthsRemedial therapy was performed within 6 to 12 months
OTHERRemedial treatment after 12 monthsRemedial therapy was performed after 12 months

Timeline

Start date
2022-09-01
Primary completion
2023-08-31
Completion
2023-12-31
First posted
2022-08-09
Last updated
2022-08-09

Source: ClinicalTrials.gov record NCT05493644. Inclusion in this directory is not an endorsement.